Whalegun
Home

Acadia Pharmaceuticals ACAD spent $600K on lobbying in Q1 2026 · Health Issues, Medicare and 1 more issue

Trade details

Type
Lobbying report
Amount
$600,000
Quarter
Q1 2026
Stock
Acadia Pharmaceuticals ACAD
Client
Acadia Pharmaceuticals
Reported
26/04/20

Up 1.7% from last quarter

What else happened in Acadia Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 03/01~04/30

Acadia Pharmaceuticals's other lobbying reports